This review article was trying to take another look at the impact of epinephrine, especially its impact on meaningful neurologic survival, to see if the debates launched by the PARAMEDIC-2 trial were
Can vitamin C benefit patients with sepsis-related ARDS? Take a look at the evidence from the CITRIS-ALI study before you take a stance in this ongoing debate.
Moderate therapeutic hypothermia could be another tool in treating cardiac arrest patients. But how much should a patient be cooled? The HYPERION Trial doesn't resolve that debate.
Ventilator alarms can be the first sign of an acute process and should be addressed immediately. It’s important to understand basic troubleshooting and move beyond DOPES when managing vent alarms.
Released in October 2019, CRASH-3 is the latest trial exploring the benefits of tranexamic acid, this time in traumatic brain injury. The bottom line: TXA hasn't been shown to reduce mortality.
About 1 in 5 patients with hypertrophic cardiomyopathy will develop atrial fibrillation. Here's how to clue in to this underlying cause of the dysrhythmia when a patient presents to you in the ED.
The SEP-1 core measure instituted by CMS has been hotly debated. A new review of literature shows a lack of high-quality evidence to back up the specificity required in the sepsis bundle.
Blunt chest trauma may be more prevalent than you realize. Sharpen your clinical gestalt by understanding the most helpful diagnostic tools, such as troponin, EKG, and echocardiography.